Literature DB >> 21279969

Growth of the acetabular lateral cartilage in relation to congenital and developmental dysplasia of the hip. An histological study.

Nicola M A Portinaro1, Andrew Porteous, Antonina Parafioriti, Artemisia Panou, Michael K D Benson.   

Abstract

There are no clear explanations for the spectrum of hip dysplasia nor for the observation that in normal and dysplastic hips, final development may be unpredictable with or without treatment. Immunohistochemical and histological studies of a three month old child's acetabulae were performed. Multiple inclusions were found in the lateral ring epiphysis and in the three flanges of the triradiate cartilage. These inclusions may represent cartilage vessel systems pre-destined to form the secondary centres of ossification. Damage to the primary acetabular growth plates may occur congenitally and help to explain the spectrum of acetabular dysplasia. Damage to one or more of these centres, whether due to instability, displacement or iatrogenic injury, may cause failure of late acetabular development. Hips at risk of damage to the acetabular cartilages should be followed up longer.

Entities:  

Mesh:

Year:  2011        PMID: 21279969     DOI: 10.5301/hip.2011.6310

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  3 in total

1.  Maturation of pelvic ossification centers on computed tomography in normal children.

Authors:  Leslie E Grissom; Mary P Harty; Grace W Guo; Heidi H Kecskemethy
Journal:  Pediatr Radiol       Date:  2018-09-03

2.  The high osteotomy cut of Dega procedure for developmental dysplasia of the hip in children under 6 years of age.

Authors:  D Ming-Hua; X Rui-Jiang; L Wen-Chao
Journal:  Orthopade       Date:  2016-12       Impact factor: 1.087

3.  Acetabular Version Increases After Closure of the Triradiate Cartilage Complex.

Authors:  Christoph E Albers; Andrea Schwarz; Markus S Hanke; Karl-Philipp Kienle; Stefan Werlen; Klaus A Siebenrock
Journal:  Clin Orthop Relat Res       Date:  2017-04       Impact factor: 4.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.